References
- HollandAJClevelandDWBoveri revisited: chromosomal instability, aneuploidy and tumorigenesisNat Rev Mol Cell Biol200910747848719546858
- HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
- KopsGJWeaverBAClevelandDWOn the road to cancer: aneuploidy and the mitotic checkpointNat Rev Cancer200551077378516195750
- HisaokaMMatsuyamaAHashimotoHAberrant MAD2 expression in soft-tissue sarcomaPathol Int200858632933318477210
- RhodesDRKalyana-SundaramSMahavisnoVOncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profilesNeoplasia20079216618017356713
- SchvartzmanJMDuijfPHSotilloRCokerCBenezraRMAD2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibitionCancer Cell201119670171421665145
- SchuylerSCWuYFKuanVJThe Mad1-Mad2 balancing act – a damaged spindle checkpoint in chromosome instability and cancerJ Cell Sci2012125pt 184197420623093575
- KatoTDaigoYAragakiMOverexpression of MAD2 predicts clinical outcome in primary lung cancer patientsLung Cancer201174112413121376419
- YuLLiuSGuoWZhangBLiangYFengQUpregulation of Mad2 facilitates in vivo and in vitro osteosarcoma progressionOncol Rep20122862170217622992948
- BashirTDorrelloNVAmadorVGuardavaccaroDPaganoMControl of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligaseNature2004428697919019315014502
- MuthDGhazaryanSEckerleITranscriptional repression of SKP2 is impaired in MYCN-amplified neuroblastomaCancer Res20107093791380220424123
- HuXLiuFJiangBWangYThe expression of Skp2 in human non-small cell lung cancer and its correlation with expression of p27 proteinZhongguo Fei Ai Za Zhi200811454755020735967
- TakanamiIThe prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancerOncol Rep200513472773115756449
- OsoegawaAYoshinoITanakaSRegulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancerJ Clin Oncol200422204165417315483027
- ZhangLWangCF-box protein Skp2: a novel transcriptional target of E2FOncogene200625182615262716331253
- SotilloRHernandoEDiaz-RodriguezEMAD2 overexpression promotes aneuploidy and tumorigenesis in miceCancer Cell200711192317189715
- HaoZHuangSE3 ubiquitin ligase Skp2 as an attractive target in cancer therapyFront Biosci (Landmark Ed)20152047449025553462
- HuangJZhangFJiangLInhibition of SKP2 sensitizes bromocriptine induced apoptosis in human prolactinoma cellsCancer Res Treat Epub201672810.4143/crt.2016.017
- YangYLuYWangLSkp2 is associated with paclitaxel resistance in prostate cancer cellsOncol Rep201636155956627175797
- MaYKurtykaCABoyapalleSA small-molecule E2F inhibitor blocks growth in a melanoma culture modelCancer Res200868156292629918676853
- KurtykaCAChenLCressWDE2F inhibition synergizes with paclitaxel in lung cancer cell linesPLoS One201495e9635724831239
- SheltzerJMBlankHMPfauSJAneuploidy drives genomic instability in yeastScience201133360451026103021852501
- SolomonDAKimTDiaz-MartinezLAMutational inactivation of STAG2 causes aneuploidy in human cancerScience201133360451039104321852505
- SotilloRSchvartzmanJMSocciNDBenezraRMAD2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawalNature2010464728743644020173739
- van DeursenJMRb loss causes cancer by driving mitosis madCancer Cell20071111317222786
- MalumbresMOncogene-induced mitotic stress: p53 and pRb get mad tooCancer Cell201119669169221665141
- Pérez de CastroIde CárcerGMalumbresMA census of mitotic cancer genes: new insights into tumor cell biology and cancer therapyCarcinogenesis200728589991217259655
- ZhangSHXuAMChenXFLiDHSunMPWangYJClinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinomaHum Pathol200839121827183418715617
- ScintuMVitaleRPrencipeMGenome instability and increased expression of BUB1B and MAD2L1 genes in ductal breast cancer carcinomaCancer Lett2007254229830717498870
- WangSTsuiSTLiuCSongYLiuDEGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancerJ Hematol Oncol2016915927448564
- WangSCangSLiuDThird-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancerJ Hematol Oncol201693427071706
- IragavarapuCMustafaMAkinleyeANovel ALK inhibitors in clinical use and developmentJ Hematol Oncol201581725888090
- WuJSavoojiJLiuDSecond- and third-generation ALK inhibitors for non-small cell lung cancerJ Hematol Oncol2016911926951079
- ChanKSKohCGLiHYMitosis-targeted anti-cancer therapies: where they standCell Death Dis20123e41123076219
- WuLGrigoryanAVLiYHaoBPaganoMCardozoTJSpecific small molecule inhibitors of Skp2-mediated p27 degradationChem Biol201219121515152423261596
- UngermannovaDLeeJZhangGDallmannHGMcHenryCSLiuXHigh-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1J Biomol Screen201318891092023589337
- ChanCHMorrowJKLiCFPharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progressionCell2013154355656823911321